mRNA |
YM201636 |
GDSC1000 |
pan-cancer |
AAC |
0.085 |
0.01 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.01 |
mRNA |
OSI-027 |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.01 |
mRNA |
TKI258 |
CCLE |
pan-cancer |
AAC |
-0.12 |
0.01 |
mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.079 |
0.01 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.01 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.01 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.01 |